ProfileGDS5822 / ILMN_2544139
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 46% 13% 60% 17% 18% 42% 41% 5% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 120.146
GSM1276600PDAC Late Ablation Control 212.713
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 125.560
GSM1276603PDAC Late Ablation 21117
GSM1276604PDAC Late Ablation 311.418
GSM1303940PDAC Late Ablation_anti-CTLA4 119.142
GSM1303941PDAC Late Ablation_anti-CTLA4 219.641
GSM1303942PDAC Late Ablation_anti-CTLA4 34.15